Optical coherence tomography evaluation of pulmonary arterial vasculopathy in Systemic Sclerosis

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Schwaiger, Johannes P ^a   Loder, Christopher D ^a   Dobarro, David ^a   Kaier, Thomas ^a   Reddecliffe, Sally ^a   Schreiber, Benjamin E ^a   Handler, Clive ^a   Denton, Christopher P ^a   Coghlan, John G ^a  

^a ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; COMPLICATION; DIAGNOSTIC IMAGING; FEMALE; HEMODYNAMICS; HUMAN; MALE; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PULMONARY ARTERY; PULMONARY HYPERTENSION; SYSTEMIC SCLEROSIS; VASCULAR DISEASE;

AGED; FEMALE; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PULMONARY ARTERY; SCLERODERMA, SYSTEMIC; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR DISEASES;

EID: 85013817310     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep43304     Document Type: Article

References (24)

1. Edwards, W. D., Edwards, J. E. Clinical primary pulmonary hypertension: three pathologic types. Circulation 56, 884-888 (1977).
2. Mooi, W. J. Pathology of pulmonary hypertension. Transplant. Proc. 19, 4373-4374 (1987).
3. Palevsky, H. I., et al. Primary pulmonary hypertension. Vascular structure, morphometry, and responsiveness to vasodilator agents. Circulation 80, 1207-1221 (1989).
4. Wagenvoort, C. A., Wagenvoort, N. O. E. K. Primary Pulmonary Hypertension: A Pathologic Study of the Lung Vessels in 156 Clinically Diagnosed Cases. Circulation 42, 1163-1184 (1970).
5. Pietra, G. G., et al. Pathologic assessment of vasculopathies in pulmonary hypertension. J. Am. Coll. Cardiol. 43, 25S-32S (2004).
6. Al-Sabbagh, M. R., et al. Pulmonary arterial histology and morphometry in systemic sclerosis: a case-control autopsy study. J. Rheumatol. 16, 1038-1042 (1989).
7. Overbeek, M. J., et al. Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy. Eur. Respir. J. 34, 371-379 (2009).
8. Dorfmuller, P., et al. Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Hum. Pathol. 38, 893-902 (2007).
9. Bezerra, H. G., Costa, M. A., Guagliumi, G., Rollins, A. M., Simon, D. I. Intracoronary optical coherence tomography: a comprehensive review clinical and research applications. JACC. Cardiovasc. Interv. 2, 1035-1046 (2009).
10. Prati, F., et al. Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. Eur. Heart J. 31, 401-415 (2010).
11. Yabushita, H., et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation 106, 1640-1645 (2002).
12. Dai, Z., et al. OCT imaging for the management of pulmonary hypertension. JACC. Cardiovasc. Imaging 7, 843-845 (2014).
13. Domingo, E., et al. In vivo assessment of pulmonary arterial wall fibrosis by intravascular optical coherence tomography in pulmonary arterial hypertension: a new prognostic marker of adverse clinical follow-up. Open. Respir. Med. J. 7, 26-32 (2013).
14. Jorge, E., et al. Pulmonary vascular remodeling in mitral valve disease: An optical coherence tomography study. Int. J. Cardiol. 203, 576-578 (2016).
15. Hou, J., et al. Pulmonary vascular changes in pulmonary hypertension: optical coherence tomography findings. Circ. Cardiovasc. Imaging 3, 344-345 (2010).
16. Tatebe, S., et al. Optical coherence tomography as a novel diagnostic tool for distal type chronic thromboembolic pulmonary hypertension. Circ. J. 74, 1742-1744 (2010).
17. Jorge, E., et al. Optical coherence tomography of the pulmonary arteries: A systematic review. J. Cardiol. 67, 6-14 (2016).
18. Miura, A., et al. Three-dimensional structure of pulmonary capillary vessels in patients with pulmonary hypertension. Circulation 121, 2151-2153 (2010).
19. Olsson, K. M., et al. Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA). Circulation 129, 57-65 (2014).
20. Yonetsu, T., Bouma, B. E., Kato, K., Fujimoto, J. G., Jang, I. K. Optical coherence tomography-15 years in cardiology. Circ. J. 77, 1933-1940 (2013).
21. Colchester, R. J., et al. Broadband miniature optical ultrasound probe for high resolution vascular tissue imaging. Biomed. Opt. Express 6, 1502-1511 (2015).
22. Pulido, T., et al. Macitentan and morbidity and mortality in pulmonary arterial hypertension. N. Engl. J. Med. 369, 809-818 (2013).
23. Li, N., Zhang, S., Hou, J., Jang, I. K., Yu, B. Assessment of pulmonary artery morphology by optical coherence tomography. Heart Lung Circ. 21, 778-781 (2012).
24. Ishii, M., et al. Evaluation of pulmonary artery histopathologic findings in congenital heart disease: an in vitro study using intravascular ultrasound imaging. J. Am. Coll. Cardiol. 26, 272-276 (1995).